Industry analysts and advocates warned that the Affordable Care Act could result in high drug costs for cancer patients in certain parts of the U.S. Insurers are allowed in some states to charge patients a large share of cost for specialty drugs to treat life-changing conditions such as cancer, rheumatoid arthritis and multiple sclerosis. There is a risk that patients with the greatest needs will be discriminated against in the insurance marketplaces, threatening the goals that the ACA was intended to meet, the Leukemia & Lymphoma Society's Brian Rosen said.

Full Story:
CBS MoneyWatch

Related Summaries